Home » Topics » Regulatory

Regulatory
RSS

Lanicemine now claimed for treatment of headache

Nov. 2, 2000

Microsponge formulation of 5-FU approved by FDA for actinic keratoses

Oct. 31, 2000

Alza's Caelyx approved in E.U. for advanced ovarian cancer

Oct. 27, 2000

Unimed submits NDA for eprosartan/hydrochlorothiazide combination tablet

Oct. 27, 2000

Remicade recommended for approval in Europe for broader application

Oct. 26, 2000

First oral chemotherapy for colorectal cancer recommended for approval in Europe

Oct. 24, 2000

Once-weekly Fosamax approved by FDA

Oct. 24, 2000

Prilosec receives positive recommendation for OTC status

Oct. 24, 2000

SkyePharma's Solaraze earns FDA approval

Oct. 23, 2000

Meningococcal C meningitis vaccine approved for very young infants

Oct. 19, 2000

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Jan 23, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Jan. 23, 2026.
Cell/gene therapy sector now sustainable; China competition mounting
BioWorld
There was an upbeat message for cell and gene therapy companies in the 2026 industry update presented as the J.P. Morgan Healthcare Conference opened on Monday,...
Neurotrimin unveiled as marker in intellectual disability
BioWorld Science
Neurotrimin (NTM) is a member of the IgLON family, the disruption of which has been tied to emotional learning deficits and anxiety-like behavior in animal...
Biallelic variants in COX18 identified as cause of Charcot-Marie-Tooth disease
BioWorld Science
Charcot-Marie-Tooth (CMT) disease is a group of clinically and genetically heterogeneous sensorimotor peripheral neuropathies. It is the most frequent inherited...